Keyphrases
DANBIO Registry
100%
Clinical Practice
72%
Tumour Necrosis Factor Inhibitor (TNFi)
71%
Rheumatoid Arthritis
66%
Treatment Response
44%
Adalimumab
43%
Infliximab
43%
Etanercept
43%
Cigarette Smoking
33%
Radiographic Progression
33%
Ankylosing Spondylitis
33%
Never-smokers
33%
Influence Factors
33%
Remission Rate
33%
Hand Bone Loss
33%
Hand Bones
33%
Drug Adherence
33%
Treatment Comparison
33%
Confidence Interval
28%
C-reactive Protein
25%
Treatment Adherence
22%
Disease Activity Score 28 (DAS28)
22%
Old Age
17%
Current Smokers
16%
Anti-tumor Necrosis Factor (anti-TNF)
16%
Medicine and Dentistry
TNF Inhibitor
94%
Rheumatoid Arthritis
66%
Inflammatory Arthritis
66%
Osteoarthritis
33%
Sacroiliac Joint
33%
Ankylosing Spondylitis
33%
Magnetic Resonance Imaging
33%
C Reactive Protein
33%
Osteolysis
33%
Bone Mass
33%
Observational Study
33%
Tumor Necrosis Factor
27%
DAS28
24%
Immunoglobulin M
16%
Rheumatoid Factor
16%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammatory Arthritis
66%
Tumor Necrosis Factor Inhibitor
66%
Rheumatoid Arthritis
66%
Infliximab
45%
Etanercept
45%
Remission
33%
Ankylosing Spondylitis
33%
C Reactive Protein
33%
Tumor Necrosis Factor
27%
Prednisolone
23%
Disease Activity
21%
Rheumatoid Factor
16%
Immunoglobulin M
16%
